Pharma industry hopes for relief from GST reforms

Pharma industry hopes for relief from GST reforms
The pharmaceutical industry has long struggled with high GST rates and an inverted duty structure, raising costs and reducing affordability of medicines. Dr. Reddy’s Laboratories Chairman Satish Reddy has expressed optimism that the upcoming GST reforms will address these critical issues.

A rationalised tax framework can make essential drugs more affordable, boost domestic manufacturing, and enhance India’s global competitiveness. At a time of global uncertainty, such reforms will not only strengthen healthcare access for citizens but also reinforce India’s role as a reliable partner in global supply chains.

Comments

Popular posts from this blog

U.S. slices planned remittance tax to 3.5% from 5%

Hindi mandatory third language for primary classes in Maharashtra .

Rupee hits a new low of ₹88.09 responding to additional tariffs